| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 3, 2003
Accepted on September 5, 2003
1 Unité Mixte de Recherche 5018, Centre National de la Recherche Scientifique - Université Paul Sabatier, Institut Fédératif de Recherche 31, CHU Rangueil, 31059 Toulouse Cedex 9 (B.P.-M., M.D., A.B., K.L., L.C., L.P.) and Institut de Recherche International Servier, Courbevoie (P.D., P.R.), France
* To whom correspondence should be addressed. E-mail: penicaud{at}toulouse.inserm.fr.
Melatonin is involved in the regulation of seasonal obesity in various species, including some rodents. This involvement has been demonstrated in non-photoperiodic rodents like rats, but only in models of enhanced body weight such as genetically obese or middle-aged rats. The aim of this investigation was to determine the effects of melatonin on body weight and metabolic parameters in a model closer to that observed in Western populations, i.e. Sprague Dawley rats fed high fat diet (HFD). They were treated for 3 weeks with melatonin (30 mg/kg) 4 h after lights-on (Zeitgeber time (ZT) 4) or 1 h before lights-out (ZT11). Given at ZT11, melatonin decreased body weight gain and feed efficiency by half. Melatonin had no effect on plasma insulin level but decreased plasma glucose (13%), leptin (28%) and triglyceride (28%) levels. Furthermore, in pinealectomized HFD rats, body weight gain and feed efficiency were increased 4 weeks after surgery. Adipose tissue weight, insulinemia and glycemia had a tendency to increase. Treatment with melatonin prevented in part these changes. These data demonstrate that melatonin may act as a regulator of body weight in a model of obesity and may prevent some of the side effects on glucose homeostasis such as decreased insulin sensitivity.
This article has been cited by other articles:
![]() |
M. Sanchez-Hidalgo, Z. Lu, D.-X. Tan, M. D. Maldonado, R. J. Reiter, and R. I. Gregerman Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2208 - R2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. C. Alonso-Vale, S. Andreotti, S. B. Peres, G. F. Anhe, C. das Neves Borges-Silva, J. C. Neto, and F. B. Lima Melatonin enhances leptin expression by rat adipocytes in the presence of insulin Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E805 - E812. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |